CD38 and Hyperglycemia: The figure shows the transition from normal physiology to hyperglycemia and diabetic nephropathy, highlighting increased CD38- and PARP1-mediated NAD+ consumption, compensatory NAMPT upregulation, and subsequent SIRT1 depletion leading to mitochondrial dysfunction and renal injury.